Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Apogee Therapeutics, Inc.
apogeetherapeutics.comAI Executive Summary
AI-powered analysis of 8-K filing content
Apogee Therapeutics successfully completed a $350 million public offering of 5.75 million shares at $70 per share, with full exercise of the underwriters' option, demonstrating strong investor confidence and providing substantial capital for R&D initiatives.
Key Takeaways
Apogee raised $350 million through a public offering of 5 million shares at $70 per share, plus 750,000 additional shares from full exercise of underwriters' option
The offering was underwritten by Jefferies LLC, TD Securities (USA) LLC, Stifel Nicolaus & Company, and Guggenheim Securities
2 more takeaways
Related Filings (1)
1 more filing from Apogee Therapeutics, Inc. in the last 90 days